Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Anesth Analg
2008 Nov 01;1075:1579-86. doi: 10.1213/ane.0b013e318184b966.
Show Gene links
Show Anatomy links
The effects of volatile aromatic anesthetics on voltage-gated Na+ channels expressed in Xenopus oocytes.
Horishita T
,
Eger EI
,
Harris RA
.
???displayArticle.abstract???
Many inhaled anesthetics inhibit voltage-gated sodium channels at clinically relevant concentrations, and suppression of neurotransmitter release by these anesthetics results, at least partly, from decreased presynaptic sodium channel activity. Volatile aromatic anesthetics can inhibit N-methyl-D-aspartate (NMDA) receptor function and enhance gamma-amino butyric acid A receptor function, but these effects depend strongly on the chemical properties of the aromatic compounds. In the present study we tested whether diverse aromatic anesthetics consistently inhibit sodium channel function. We studied the effect of eight aromatic anesthetics on Na(v)1.2 sodium channels with beta(1) subunits, using whole-cell, two-electrode voltage-clamp techniques in Xenopus oocytes. All aromatic anesthetics inhibited I(Na) (sodium currents) at a holding potential which produce half-maximal current (V(1/2)) (partial depolarization); inhibition was modest with 1,3,5-trifluorobenzene (8% +/- 2%), pentafluorobenzene (13% +/- 2%), and hexafluorobenzene (13% +/- 2%), but greater with benzene (37% +/- 2%), fluorobenzene (39% +/- 2%), 1,2-difluorobenzene (48% +/- 2%), 1,4-difluorobenzene (31 +/- 3%), and 1,2,4-trifluorobenzene (33% +/- 1%). Such dichotomous effects were noted by others for NMDA and gamma-aminobutyric acid A receptors. Parallel, but much smaller inhibition, was found for I(Na) at a holding potential which produced near maximal current (-90 mV) (V(H-90)), and hexafluorobenzene caused small (6% +/- 1%) enhancement of this current. These changes in sodium channel function were correlated with effectiveness for inhibiting NMDA receptors, with lipid solubility of the compounds, with molecular volume, and with cation-pi interactions. Aromatic compounds vary in their actions on the kinetics of sodium channel gating and this may underlie their variable inhibition. The range of inhibition produced by minimum alveolar anesthetic concentration concentrations of inhaled anesthetics indicates that sodium channel inhibition may underlie the action of some of these anesthetics, but not others.
Antognini,
Exaggerated anesthetic requirements in the preferentially anesthetized brain.
1993, Pubmed
Antognini,
Exaggerated anesthetic requirements in the preferentially anesthetized brain.
1993,
Pubmed
Catterall,
International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.
2005,
Pubmed
Catterall,
From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.
2000,
Pubmed
Fang,
Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis.
1996,
Pubmed
Franks,
Molecular targets underlying general anaesthesia.
2006,
Pubmed
Franks,
Molecular and cellular mechanisms of general anaesthesia.
1994,
Pubmed
Franks,
How does xenon produce anaesthesia?
1998,
Pubmed
Goldin,
Resurgence of sodium channel research.
2001,
Pubmed
Horishita,
n-Alcohols inhibit voltage-gated Na+ channels expressed in Xenopus oocytes.
2008,
Pubmed
,
Xenbase
Kelly,
Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.
2007,
Pubmed
,
Xenbase
Koblin,
Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis.
1994,
Pubmed
Lingamaneni,
Widespread inhibition of sodium channel-dependent glutamate release from isolated nerve terminals by isoflurane and propofol.
2001,
Pubmed
Martin,
Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors.
1995,
Pubmed
Mihic,
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.
1997,
Pubmed
,
Xenbase
Neal,
The analgesic and anaesthetic actions of tetrafluorobenzene.
1966,
Pubmed
Ouyang,
Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals.
2003,
Pubmed
OuYang,
Isoform-selective effects of isoflurane on voltage-gated Na+ channels.
2007,
Pubmed
Raines,
The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions.
2004,
Pubmed
,
Xenbase
Ratnakumari,
Inhibition of presynaptic sodium channels by halothane.
1998,
Pubmed
Ratnakumari,
Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels.
2000,
Pubmed
Rehberg,
Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics.
1996,
Pubmed
Schlame,
Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism.
1995,
Pubmed
Shiraishi,
Effects of alcohols and anesthetics on recombinant voltage-gated Na+ channels.
2004,
Pubmed
,
Xenbase
Solt,
Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics.
2006,
Pubmed
,
Xenbase
Westphalen,
Selective depression by general anesthetics of glutamate versus GABA release from isolated cortical nerve terminals.
2003,
Pubmed
Wu,
Isoflurane inhibits transmitter release and the presynaptic action potential.
2004,
Pubmed
